ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 142 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,049,000 | -33.5% | 142,706 | -9.1% | 0.00% | 0.0% |
| Q4 2020 | $3,080,000 | +58.1% | 156,913 | +4.4% | 0.00% | 0.0% |
| Q3 2020 | $1,948,000 | +15.1% | 150,300 | +29.3% | 0.00% | 0.0% |
| Q2 2020 | $1,693,000 | +73.6% | 116,200 | +1.5% | 0.00% | +100.0% |
| Q1 2020 | $975,000 | -44.5% | 114,519 | +7.4% | 0.00% | -50.0% |
| Q4 2019 | $1,756,000 | +116.8% | 106,619 | +85.9% | 0.00% | +100.0% |
| Q3 2019 | $810,000 | +10.7% | 57,345 | +57.5% | 0.00% | 0.0% |
| Q2 2019 | $732,000 | -47.2% | 36,400 | +4.3% | 0.00% | -50.0% |
| Q1 2019 | $1,387,000 | -20.5% | 34,900 | -30.5% | 0.00% | 0.0% |
| Q4 2018 | $1,745,000 | -9.0% | 50,240 | +8.4% | 0.00% | 0.0% |
| Q3 2018 | $1,917,000 | +10.2% | 46,366 | -2.0% | 0.00% | 0.0% |
| Q2 2018 | $1,739,000 | -21.1% | 47,329 | -16.2% | 0.00% | -33.3% |
| Q1 2018 | $2,203,000 | – | 56,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |